Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gentamicin nephrotoxicity: application of multivariate analysis

R T Taketomo, W F McGhan, M R Fushiki

    Clinical Pharmacy
    |November 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Direct comparison of the effects of first- and second-generation H<sub>1</sub> -receptor blockers on motor functions in mice.

    Die Pharmazie·2025
    Same author

    Clinical jaw-muscle symptoms in a group of probable sleep bruxers.

    Journal of dentistry·2019
    Same author

    Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel.

    International journal of laboratory hematology·2018
    Same author

    Insulin degludec overdose may lead to long-lasting hypoglycaemia through its markedly prolonged half-life.

    Diabetic medicine : a journal of the British Diabetic Association·2017
    Same author

    Authors' reply to the comment by Fernstrom.

    European journal of pain (London, England)·2017
    Same author

    Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia.

    Leukemia·2017

    Identifying patient risk factors for gentamicin nephrotoxicity proved challenging. While multivariate analysis revealed key factors like concurrent drug use and trough concentration, predictive models were not satisfactory for general use.

    Area of Science:

    • Pharmacology
    • Nephrology
    • Clinical Toxicology

    Background:

    • Gentamicin is a widely used antibiotic.
    • Nephrotoxicity is a significant adverse effect of gentamicin therapy.
    • Identifying predictive risk factors for gentamicin-induced kidney damage is crucial for patient safety.

    Purpose of the Study:

    • To identify patient-specific risk factors associated with gentamicin nephrotoxicity.
    • To evaluate the efficacy of multivariate analysis in differentiating toxic from nontoxic patients.
    • To assess the potential for developing a generalized predictive model for gentamicin nephrotoxicity.

    Main Methods:

    • Retrospective study design.
    • Inclusion of 220 patients (103 male, 117 female).

    Related Experiment Videos

  • Multivariate discriminant analysis to identify risk factors for nephrotoxicity, considering factors like serum creatinine, drug concentration, and concurrent medications.

    • Main Results:

    • Variables such as height, weight, sex, dose, peak concentration, age, and initial renal function were not significant discriminators.
    • Significant factors included complicating factors with nephrotoxic potential, number of concurrent nephrotoxic drugs, trough gentamicin concentration (intensity index), and treatment duration/total dose.
    • Developed discriminant models showed moderate classification accuracy (63.5-65.4% for toxic, 68.8-72.1% for nontoxic).

    Conclusions:

    • Multivariate techniques are essential for differentiating variables contributing to gentamicin nephrotoxicity.
    • The developed predictive models were not satisfactory for widespread clinical application.
    • Further research is needed to refine predictive models for gentamicin-induced kidney injury.